Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II-Reference-Cited by-同舟云学术

Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II

Published:2023-03 Issue:3 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Criscuolo Elena¹^ORCID,Giuliani Benedetta¹^ORCID,Ferrarese Roberto¹^ORCID,Ferrari Davide²^ORCID,Locatelli Massimo³,Clementi Massimo¹⁴,Mancini Nicasio¹³^ORCID,Clementi Nicola¹³^ORCID

Affiliation:

1. Laboratory of Microbiology and Virology Vita‐Salute San Raffaele University Milan Italy

2. SCVSA Department University of Parma Parma Italy

3. IRCCS San Raffaele Hospital Milan Italy

4. Synlab Italia Castenedolo (BS) Italy

Abstract

AbstractSince early May 2022, some monkeypox virus (MPXV) infections have been reported from countries where the disease is not endemic. Within 2 months, the number of patients has increased extensively, becoming the most considerable MPXV outbreak described. Smallpox vaccines demonstrated high efficacy against MPXVs in the past and are considered a crucial outbreak control measure. However, viruses isolated during the current outbreak carry distinct genetic variations, and the cross‐neutralizing capability of antibodies remains to be assessed. Here we report that serum antibodies elicited by first‐generation smallpox vaccines can neutralize the current MPXV more than 40 years after vaccine administration.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28643

Reference25 articles.

1. The changing epidemiology of human monkeypox—A potential threat? A systematic review

2. Re-emergence of monkeypox in Africa: a review of the past six years

3. Centers for Disease Control and Prevention (CDC). 2022 Global map & case count. November 15 2022. Accessed December 29 2022.https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html

4. World Health Organization (WHO). WHO director‐general declares the ongoing monkeypox outbreak a public health emergency of international concern. 2022. Accessed November 16 2022.https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern

5. Vaccines for preventing smallpox;Metzger W;Cochrane Database Syst Rev,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the acute antibody response of monkeypox and MVA‐BN vaccine following an Australian outbreak;Journal of Medical Virology;2024-01

2. Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: evidence from mouse and rhesus monkey models;Emerging Microbes & Infections;2023-12-06

3. Serological methods for the detection of antibodies against monkeypox virus applicable for laboratories with different biosafety levels;Journal of Medical Virology;2023-12

4. Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history;BMC Biology;2023-10-02

5. Molybdenum disulfide-loaded multilayer AuNPs with colorimetric-SERS dual-signal enhancement activities for flexible immunochromatographic diagnosis of monkeypox virus;Journal of Hazardous Materials;2023-10